Medifast, Inc. MED
12.97 USD +0.11 (+0.86%)
Regular-session close
12.97 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
12.78 Day range 13.02
9.45 52-week range 13.37
- YTD
- +21.44%
- 1 year
- +13.18%
News
zacks.com Will Medifast's Metabolic Health Institute Strengthen Its Edge? MED advances its metabolic health strategy through a new Institute, proprietary science and Trilivy's phased wellness system.
fool.com Medifast: 3 Key Takeaways for Long-Term Investors Average revenue per active coach rose 54% year over year. Medifast ended the third quarter with $172.5 million in cash.
seekingalpha.com Medifast Is Running The Same Playbook, And I Have The Same Concerns Medifast (MED) maintains a strong, cash-heavy balance sheet and trades near liquidation value, but its business model remains uninspiring amid GLP-1 disruption. Q3 2026 revenue declined 19.4% YoY to…
zacks.com Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises MED tops Q3 earnings expectations as coach productivity jumps 54.1% and margins expand, despite declining revenues and a shrinking coach network.
seekingalpha.com Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript
marketbeat.com What Medifast (MED) Said on Its Q3 Earnings Call Medifast NYSE: MED reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management…
zacks.com Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates Medifast (MED) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.21 per share a year ago.
benzinga.com Medifast Q3 2026 Earnings Call Transcript Medifast (NYSE:MED) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Medifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est Medifast (NYSE:MED) lowers FY2026 GAAP EPS guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) analyst estimate..- benzinga.com Medifast Sees FY2026 Adj EPS $(0.70)-$(0.45) vs $(0.94) Est; Raises FY2026 Sales Guidance from $270.000M-$300.000M to $280.000M-$300.000M vs $287.700M Est Medifast (NYSE:MED) is looking for FY2026 Adj EPS of $(0.70)-$(0.45) vs $(0.94) analyst estimate. Raises FY2026 sales outlook from $270.000 million-$300.000 million to $280.000 million-$300.000…
benzinga.com Medifast Q3 Adj. EPS $(0.19) Beats $(0.35) Estimate, Sales $72.048M Beat $71.300M Estimate Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.35) by 45.71 percent. This is a 9.52 percent increase over losses of $(0.21) per…
benzinga.com Medifast Sees Q4 GAAP EPS $0.00-$0.25 vs $(0.12) Est; Sees Sales $55.000M-$75.000M vs $64.100M Est Medifast (NYSE:MED) is looking for Q4 GAAP EPS of $0.00-$0.25 vs $(0.12) analyst estimate. sees sales of $55.000 million-$75.000 million vs $64.100 million analyst estimate.
businesswire.com Medifast Announces Third Quarter 2026 Financial Results BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for…
zacks.com Medifast Q3 Earnings on the Horizon: Key Insights for Investors MED's Q3 results are likely to face pressure from GLP-1 adoption, shrinking coach numbers and lower sales, while strategic initiatives may offer some support.
globenewswire.com Why Is Weight Loss Different During Menopause? Common Myths Debunked Myth: Menopause weight gain is inevitable. Truth: Acceleration is not inevitable.
businesswire.com Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026 BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, will announce financial…
zacks.com Best Momentum Stocks to Buy for October 14th NUE, CNK and MED made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 14, 2026.
zacks.com New Strong Buy Stocks for October 14th NATL, BGC, CCNE, FRME and UVSP have been added to the Zacks Rank #1 (Strong Buy) List on October 14, 2026.
globenewswire.com 5 Questions People Ask When Every Weight Loss Approach Has Failed Trilivy's™ mission is lifelong transformation through metabolic science and human connection Baltimore, MD, Oct. 13, 2026 (GLOBE NEWSWIRE) -- When every weight loss approach has failed , individuals…
globenewswire.com What Actually Keeps Weight Off After a Weight Loss Program Baltimore, MD, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Weight regain after initial weight loss is a recognized pattern among individuals pursuing lasting metabolic change. Trilivy™, a science-backed,…
zacks.com Can Medifast's Better Client Retention Support Revenue Stabilization? MED's revenue is stabilizing as coach productivity and client retention improve, though a shrinking coach base continues to weigh on results.
globenewswire.com Why Do You Keep Gaining Weight Back After Losing It Baltimore, MD, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Weight comes back after weight loss when the conditions that drove it were never addressed during the weight loss phase. Trilivy™, a science-backed,…
globenewswire.com What Are the 5 Signs of Poor Metabolic Health Adults May Overlook? Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult to analyze without a clinical framework. Trilivy™, a science-backed, coach-guided metabolic health…
globenewswire.com Why Weight Loss Plateaus Happen: 5 Metabolic Causes Trilivy™ is designed to address the challenges of metabolic dysfunction Clients on Trilivy's Reset 5 & 1 Plan who work with a coach lose up to 10 times more weight and 17 times more fat compared to…
zacks.com Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.
benzinga.com 11 Consumer Staples Stocks Moving In Monday's After-Market Session Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came…- benzinga.com Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.
benzinga.com Medifast Q2 Adj. EPS $(0.28) Beats $(0.65) Estimate, Sales $76.384M Beat $72.700M Estimate Medifast (NYSE:MED) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.65) by 56.92 percent. This is a 227.27 percent decrease over earnings of $0.22 per…- benzinga.com Medifast Launches Trilivy, Comprehensive Metabolic Health System; Co. Also Unveils Newly Formulated Meal Replacements, Including Trilivy Reset Fueling Line Enhanced With MetaVantage Technology The leading health and wellness company unveils an evolutionary transformation from weight loss to optimal metabolic health, powered by breakthrough science and human connectionMedifast, Inc.…
- benzinga.com Medifast Affirms FY2026 GAAP EPS Guidance of $(2.75)-$(1.55) vs $(1.98) Est; Affirms FY2026 Sales Guidance of $270.000M-$300.000M vs $273.700M Est Medifast (NYSE:MED) affirms FY2026 GAAP EPS guidance from $(2.75)-$(1.55) to $(2.75)-$(1.55) vs $(1.98) analyst estimate. Affirms FY2026 sales outlook from $270.000 million-$300.000 million to…
benzinga.com Medifast Sees Q2 GAAP EPS $(1.00)-$(0.50) vs $(0.43) Est; Sees Sales $60.000M-$80.000M vs $74.700M Est Medifast (NYSE:MED) is looking for Q2 GAAP EPS of $(1.00)-$(0.50) vs $(0.43) analyst estimate. sees sales of $60.000 million-$80.000 million vs $74.700 million analyst estimate.
benzinga.com Medifast Q1 EPS $(0.19) Beats $(0.52) Estimate, Sales $76.044M Beat $69.200M Estimate Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.52) by 63.46 percent. This is a 171.43 percent decrease over losses of $(0.07) per…
benzinga.com Earnings Scheduled For May 4, 2026 
benzinga.com 12 Consumer Staples Stocks Moving In Wednesday's After-Market Session 
benzinga.com Medifast Agrees To Nominate Steamboat Capital Partners' Parsa Kiai, Jeff Rose As Independent Director Candidates Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Directors has agreed to…
benzinga.com Medifast Announces Availability Of OPTAVIA's Comprehensive Metabolic Health System For Reimbursement On Select Insurance Plans Using Health Savings Accounts, Flexible Spending Accounts Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for reimbursement on select insurance plans using Health Savings Accounts (HSA) and Flexible…- benzinga.com Stephens & Co. Maintains Equal-Weight on Medifast, Lowers Price Target to $12 Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lowers the price target from $15 to $12.
benzinga.com Medifast Q4 2025 Earnings Call Transcript - benzinga.com Earnings Scheduled For February 17, 2026
benzinga.com What to Expect from Medifast's Earnings 
benzinga.com Earnings Scheduled For November 3, 2025 - benzinga.com Earnings Scheduled For August 4, 2025
- benzinga.com Earnings Scheduled For April 28, 2025
- benzinga.com Earnings Scheduled For February 18, 2025
- benzinga.com Gold Down Over 2%; 3M Profit Beats Expectations
- benzinga.com Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
- benzinga.com Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings
benzinga.com Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly…- benzinga.com Earnings Scheduled For February 20, 2024 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.